Ratings Encres DUBUIT

Equities

ALDUB

FR0004030708

Real-time Euronext Paris 08:41:02 02/05/2024 BST 5-day change 1st Jan Change
2.96 EUR -0.67% Intraday chart for Encres DUBUIT -6.33% -8.64%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The stock, which is currently worth 2023 to 0.27 times its sales, is clearly overvalued in comparison with peers.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Specialty Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
-8.64% 9.68M -
+8.93% 3.99B
D+
+4.74% 1.77B
B+
+8.36% 1.03B -
D+
+11.26% 980M -
+74.92% 789M - -
-5.93% 668M - -
+2.08% 569M -
+15.32% 503M -
-2.76% 418M -
D+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality